Effectiveness and Renal Safety of TAF in Chronic HBV Effectiveness and Renal Safety of TAF in Chronic HBV
How does the renal safety of tenofovir alafenamide fumarate compare to that of tenofovir disoproxil fumarate in a real-world clinical setting? Can switching from TDF to TAF reverse renal impairment?Journal of Viral Hepatitis (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - July 6, 2021 Category: Intensive Care Tags: Gastroenterology Journal Article Source Type: news
Outcomes Associated With Change From TDF to TAF in HIV-1 Outcomes Associated With Change From TDF to TAF in HIV-1
A new study looks at the effects of a treatment switch from tenofovir disoproxil fumarate to tenofovir alafenamide-containing ART regimens among HIV-1-infected patientsHIV Medicine (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 1, 2021 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news
Temixys (lamivudine and tenofovir disoproxil fumarate)
Title: Temixys (lamivudine and tenofovir disoproxil fumarate)Category: MedicationsCreated: 6/16/2021 12:00:00 AMLast Editorial Review: 6/16/2021 12:00:00 AM (Source: MedicineNet HIV General)
Source: MedicineNet HIV General - June 16, 2021 Category: Infectious Diseases Source Type: news
HIV has detrimental effect on children ’ s growth and bone strength, finds landmark study
Children growing up with HIV infection have concerning deficits in skeletal strength which become more apparent towards the end of pubertal growth, finds the largest study to date to investigate the link between HIV and skeletal health in children. The study, conducted in Zimbabwe and published in The Lancet Child and Adolescent Health, identifies a link between these skeletal deficits and the first-line antiretroviral-HIV drug, tenofovir disproxil fumarate (TDF), which is widely used across sub-Saharan Africa. (Source: University of Bristol news)
Source: University of Bristol news - June 14, 2021 Category: Universities & Medical Training Tags: Research, International, Health; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news
Lupin gets USFDA nod to market generic HIV drug
The company has received approval from the United States Food and Drug Administration (USFDA) to market its Emtricitabine and Tenofovir Disoproxil Fumarate tablets, 200 mg/300 mg, Lupin said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 7, 2021 Category: Pharmaceuticals Source Type: news
Complera (emtricitabine, rilpivirine, tenofovir disoproxil fumarate)
Title: Complera (emtricitabine, rilpivirine, tenofovir disoproxil fumarate)Category: MedicationsCreated: 5/27/2021 12:00:00 AMLast Editorial Review: 5/27/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 27, 2021 Category: Drugs & Pharmacology Source Type: news
Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide)
Title: Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide)Category: MedicationsCreated: 4/30/2021 12:00:00 AMLast Editorial Review: 4/30/2021 12:00:00 AM (Source: MedicineNet HIV General)
Source: MedicineNet HIV General - April 30, 2021 Category: Infectious Diseases Source Type: news
Replacing TDF With TAF for HIV Tied to Adverse Metabolic Changes
FRIDAY, April 9, 2021 -- For people with HIV receiving tenofovir-based antiretroviral therapy (ART), replacing tenofovir disoproxil fumarate (TDF) with tenofovir alafenamide (TAF) is associated with adverse metabolic changes, including weight... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2021 Category: Pharmaceuticals Source Type: news
Study Reinforces Need to Monitor Kidney Function in Long-Term PrEP Users Study Reinforces Need to Monitor Kidney Function in Long-Term PrEP Users
In people taking tenofovir-based PrEP, established biomarkers of kidney injury may be elevated in patients with and without clinical evidence of kidney injury, researchers have found.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 6, 2021 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
Dyslipidemia After Switch to TAF-Based cART in HIV Patients Dyslipidemia After Switch to TAF-Based cART in HIV Patients
Switching from tenofovir to tenofovir alafenamide may cause lipid profile changes in HIV patients. What are the clinical implications?HIV Medicine (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - March 17, 2021 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news
Certain HIV Meds May Trigger Weight Gain
New research raises questions about one drug featured in many ART recipes: tenofovir alafenamide, also known as TAF. (Source: WebMD Health)
Source: WebMD Health - March 16, 2021 Category: Consumer Health News Source Type: news
Strides Pharma Science arm gets USFDA nod for HIV treatment drug
Drug firm Strides Pharma Science on Friday said its step-down wholly-owned subsidiary, Strides Pharma Global, has received approval from the US health regulator for Emtricitabine and Tenofovir Disoproxil Fumarate tablets, used to treat HIV. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 15, 2021 Category: Pharmaceuticals Source Type: news
Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate
How do these two antiretroviral regimens for HIV compare in terms of safety and efficacy?AIDS (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - December 4, 2020 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news
MTX Decreases Tenofovir Exposure in ART-Suppressed HIV MTX Decreases Tenofovir Exposure in ART-Suppressed HIV
A new study finds that methotrexate may alter tenofovir exposure among virally suppressed people living with HIV. Does this warrant a change in dosing during the co-administration of these drugs?JAIDS: Journal of Acquired Immune Deficiency Syndromes (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 30, 2020 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news
Mixed Outcomes in Tenofovir Trial for Chronic Hepatitis B Mixed Outcomes in Tenofovir Trial for Chronic Hepatitis B
Levels of surface antigen loss were low whether or not patients treated with tenofovir also received interferon, but some patients met criteria for inactive chronic disease after therapy withdrawal.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
